NCT03541928 2021-04-06
Phase II High Risk Prostate Cancer Trial Using Gene & Androgen Deprivation Therapies, Radiotherapy, & Surgery
The Methodist Hospital Research Institute
Phase 2 Unknown
The Methodist Hospital Research Institute
SonaCare Medical
University of Erlangen-Nürnberg Medical School
Sheba Medical Center
University Hospital Erlangen